Schedule 13G ownership disclosure
BRIDGEBIO PHARMA INC
Security class unavailable · CUSIP: 10806X102
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,591,455
- Percent of class
- 7.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-015498
- Form type
- SC 13G
- Filer
- BridgeBio Pharma, Inc.
- CIK
- CIK 1743881
- Filed
- Feb 09, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership